Association of MMP-2 and MMP-9 Polymorphisms with Diabetes and Pathogenesis of Diabetic Complications

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Sep 23

PMID 36142480

Authors

Beata Gajewska

Mariola Sliwinska-Mosson

Affiliations

Soon will be listed here.

Abstract

Type 2 diabetes mellitus (T2D) affects millions of people around the world, and its complications have serious health consequences. In addition to external factors, the causes of morbidity and increased risk were also sought in the variability of the human genome. A phenomenon that can answer these questions is the occurrence of single-nucleotide polymorphisms (SNP). They constitute a field for research into genetic determinants responsible for the increase in the risk of the discussed metabolic disease. This article presents the outline of two enzymes: metalloproteinases 2 and 9 (MMP-2, MMP-9), their biological activity and the effect caused by differences in individual alleles in the population, as well as the reports on the importance of these DNA sequence variations in the occurrence of diabetes mellitus type 2 and associated conditions. The results of the conducted research indicate a relationship between two MMP-2 polymorphisms (rs243865, rs243866) and two MMP-9 polymorphisms (rs3918242, rs17576) and the presence of T2D. This could offer a promising possibility to use them as predictive and diagnostic markers. However, due to the low number of reports, more research is needed to clearly confirm the link between these SNPs and diabetes.

Citing Articles

Dynamic changes of MMPs during cerebral aneurysm formation in rats and the effect of resveratrol on MMP expression.

Li N, Fan C, Li X, Su J Am J Transl Res. 2024; 16(10):5347-5356.

PMID: 39544733 PMC: 11558362. DOI: 10.62347/LKIU6905.

The emerging modulators of non-coding RNAs in diabetic wound healing.

Aghayants S, Zhu J, Yu J, Tao R, Li S, Zhou S Front Endocrinol (Lausanne). 2024; 15:1465975.

PMID: 39439564 PMC: 11493653. DOI: 10.3389/fendo.2024.1465975.

The Association of MMP-2, MMP-9, and MMP-13 Gene Polymorphisms With Knee Osteoarthritis in the Greek Population.

Milaras C, Lepetsos P, Pampanos A, Kenanidis E, Macheras G, Mavrogianni D Cureus. 2024; 16(7):e65379.

PMID: 39184681 PMC: 11344598. DOI: 10.7759/cureus.65379.

Transcriptomic Signature and Pro-Osteoclastic Secreted Factors of Abnormal Bone-Marrow Stromal Cells in Fibrous Dysplasia.

Michel Z, Raborn L, Spencer T, Pan K, Martin D, Roszko K Cells. 2024; 13(9.

PMID: 38727310 PMC: 11083355. DOI: 10.3390/cells13090774.

Text Mining and Drug Discovery Analysis: A Comprehensive Approach to Investigate Diabetes-Induced Osteoporosis.

Wang C, Hu Y, Liang F Int J Med Sci. 2024; 21(3):464-473.

PMID: 38250601 PMC: 10797669. DOI: 10.7150/ijms.90829.

References

Zhao R, Zhou H, Zhu J . MMP-9-C1562T polymorphism and susceptibility to chronic obstructive pulmonary disease: A meta-analysis. Medicine (Baltimore). 2020; 99(31):e21479. PMC: 7402884. DOI: 10.1097/MD.0000000000021479. View

Li H, Huang J, Yang B, Xiang T, Yin X, Peng W . Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and β-catenin signaling pathway. Toxicol Appl Pharmacol. 2013; 272(1):180-90. DOI: 10.1016/j.taap.2013.05.011. View

Perez-Hernandez N, Vargas-Alarcon G, Martinez-Rodriguez N, Martinez-Rios M, Pena-Duque M, de la Pena-Diaz A . The matrix metalloproteinase 2-1575 gene polymorphism is associated with the risk of developing myocardial infarction in Mexican patients. J Atheroscler Thromb. 2012; 19(8):718-27. DOI: 10.5551/jat.11817. View

Zhang Z, Wu X, Cai T, Gao W, Zhou X, Zhao J . Matrix Metalloproteinase 9 Gene Promoter (rs 3918242) Mutation Reduces the Risk of Diabetic Microvascular Complications. Int J Environ Res Public Health. 2015; 12(7):8023-33. PMC: 4515707. DOI: 10.3390/ijerph120708023. View

Saravani S, Yari D, Saravani R, Azadi Ahmadabadi C . Association of (rs55703767), (rs17576)and (rs6609533) gene polymorphisms with susceptibility to type 2 diabetes. Biomed Rep. 2017; 6(3):329-334. PMC: 5403448. DOI: 10.3892/br.2017.856. View

Safranek J, Pesta M, Holubec L, Kulda V, Dreslerova J, Vrzalova J . Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease. Anticancer Res. 2009; 29(7):2513-7. View

Sarray S, Dallel M, Lamine L, Jairajpuri D, Sellami N, Turki A . Association of matrix metalloproteinase-2 gene polymorphisms with susceptibility to type 2 diabetes: A case control study. J Diabetes Complications. 2021; 35(6):107908. DOI: 10.1016/j.jdiacomp.2021.107908. View

Belo V, Luizon M, Carneiro P, Gomes V, Lacchini R, Lanna C . Effect of metabolic syndrome risk factors and MMP-2 genetic variations on circulating MMP-2 levels in childhood obesity. Mol Biol Rep. 2012; 40(3):2697-704. DOI: 10.1007/s11033-012-2356-7. View

Kamal A, Elgengehy F, Abd Elaziz M, Gamal S, Sobhy N, Medhat A . Matrix Metalloproteinase-9 rs17576 Gene Polymorphism and Behçet's Disease: Is There an Association?. Immunol Invest. 2017; 46(5):460-468. DOI: 10.1080/08820139.2017.1296857. View

10.

Yadav S, Mandal R, Singh M, Dwivedi P, Sethi R, Usman K . Cumulative Risk of Metabolic Syndrome Correlated with the Coexistence of (-1306C/T) and Altered Circulating MMP2 level. Exp Clin Endocrinol Diabetes. 2016; 124(6):380-4. DOI: 10.1055/s-0042-104497. View

11.

Cheng J, Hao X, Zhang Z . Risk of macular degeneration affected by polymorphisms in Matrix metalloproteinase-2: A case-control study in Chinese Han population. Medicine (Baltimore). 2018; 96(47):e8190. PMC: 5708910. DOI: 10.1097/MD.0000000000008190. View

12.

Wilson P, DAgostino R, Parise H, Sullivan L, Meigs J . Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005; 112(20):3066-72. DOI: 10.1161/CIRCULATIONAHA.105.539528. View

13.

Mohammadhosayni M, Khosrojerdi A, Lorian K, Aslani S, Imani D, Razi B . Matrix metalloproteinases (MMPs) family gene polymorphisms and the risk of multiple sclerosis: systematic review and meta-analysis. BMC Neurol. 2020; 20(1):218. PMC: 7257507. DOI: 10.1186/s12883-020-01804-2. View

14.

Yang J, Fan X, Guan Y, Li Y, Sun W, Yang X . MMP-2 gene polymorphisms in type 2 diabetes mellitus diabetic retinopathy. Int J Ophthalmol. 2012; 3(2):137-40. PMC: 3340781. DOI: 10.3980/j.issn.2222-3959.2010.02.10. View

15.

Wang Y, Su Y, Xu Y, Pan S, Liu G . Genetic polymorphism c.1562C>T of the MMP-9 is associated with macroangiopathy in type 2 diabetes mellitus. Biochem Biophys Res Commun. 2009; 391(1):113-7. DOI: 10.1016/j.bbrc.2009.11.012. View

16.

Uhlen M, Fagerberg L, Hallstrom B, Lindskog C, Oksvold P, Mardinoglu A . Proteomics. Tissue-based map of the human proteome. Science. 2015; 347(6220):1260419. DOI: 10.1126/science.1260419. View

17.

Zhang L, Mi Y, Cao Q, Wang W, Qin C, Wei J . Update analysis of studies on the MMP-9 -1562 C>T polymorphism and cancer risk. Mol Biol Rep. 2011; 39(4):3435-41. DOI: 10.1007/s11033-011-1115-5. View

18.

Fagerberg L, Hallstrom B, Oksvold P, Kampf C, Djureinovic D, Odeberg J . Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics. 2013; 13(2):397-406. PMC: 3916642. DOI: 10.1074/mcp.M113.035600. View

19.

Xu T, Zhang S, Qiu D, Li X, Fan Y . Association between matrix metalloproteinase 9 polymorphisms and breast cancer risk: An updated meta-analysis and trial sequential analysis. Gene. 2020; 759:144972. DOI: 10.1016/j.gene.2020.144972. View

20.

Zou F, Zhang J, Xiang G, Jiao H, Gao H . Association of Matrix Metalloproteinase 9 () Polymorphisms with Asthma Risk: A Meta-Analysis. Can Respir J. 2019; 2019:9260495. PMC: 6410464. DOI: 10.1155/2019/9260495. View